scispace - formally typeset
S

Stefan Karlsson

Researcher at Lund University

Publications -  303
Citations -  20537

Stefan Karlsson is an academic researcher from Lund University. The author has contributed to research in topics: Stem cell & Haematopoiesis. The author has an hindex of 70, co-authored 292 publications receiving 19180 citations. Previous affiliations of Stefan Karlsson include deCODE genetics & Netherlands Cancer Institute.

Papers
More filters
Journal Article

The effect of single-side ion exchange on the flexural strength of plain float glass and float glass containing a drilled hole

TL;DR: In this paper, the effect of single-side ion exchange (using a KNO3:KCl mixture) on the ring-on-ring flexural strength of float glass has been studied.
Journal Article

Regulated expression of human globin genes following transfer with retroviral vectors.

TL;DR: In this article, retroviral vectors containing human globin genes (gamma-beta hybrid gene or beta globin gene) were constructed and transferred into mouse erythroleukemia cells and obtained regulated expression of human Globin mRNA and protein.

CONCISE REVIEW Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications

TL;DR: The basic principles of different SC systems are reviewed, and on the basis of the experience with HSC-based SC therapy, recommendations for clinical application of emerging SC technologies are provided.
Journal ArticleDOI

HOXA10 Affects the Fate of Hematopoietic Progenitors and Stem Cells in a Concentration Dependent Manner.

TL;DR: An inducible system based on a tetracycline transactivator controlling the expression of HOXA10 was generated, aiming to study how different concentrations of HOxA10 affect the fate of hematopoietic progenitors and stem cells.
Journal ArticleDOI

96. Enforced HoxB4 Expressed Hematopoietic Stem Cells Transdifferentiate into Oligodendrocytes in Adult Mouse Brain

TL;DR: The data strongly support that HSCs transduced with HoxB4 expression vector are useful for ex vivo gene therapy of CNS disorders as carriers of production of therapeutic protein and for regeneration of oligodendrocytes to treat demyelinating disorders such as MLD, Krabbe disease, and multiple sclerosis.